Compare Abbott India with Suven Life Sciences - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs SUVEN LIFE SCIENCES - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA SUVEN LIFE SCIENCES ABBOTT INDIA/
SUVEN LIFE SCIENCES
 
P/E (TTM) x 47.2 -9.4 - View Chart
P/BV x 14.7 16.2 91.1% View Chart
Dividend Yield % 1.5 0.0 -  

Financials

 ABBOTT INDIA   SUVEN LIFE SCIENCES
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-21
SUVEN LIFE SCIENCES
Mar-21
ABBOTT INDIA/
SUVEN LIFE SCIENCES
5-Yr Chart
Click to enlarge
High Rs18,569109 17,035.8%   
Low Rs13,97019 72,196.9%   
Sales per share (Unadj.) Rs2,028.21.1 191,538.1%  
Earnings per share (Unadj.) Rs325.0-5.7 -5,733.8%  
Cash flow per share (Unadj.) Rs352.4-5.3 -6,614.8%  
Dividends per share (Unadj.) Rs275.000-  
Avg Dividend yield %1.70-  
Book value per share (Unadj.) Rs1,203.75.6 21,552.6%  
Shares outstanding (eoy) m21.25127.28 16.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x8.060.6 13.2%   
Avg P/E ratio x50.1-11.3 -442.1%  
P/CF ratio (eoy) x46.2-12.0 -383.2%  
Price / Book Value ratio x13.511.5 117.6%  
Dividend payout %84.60-   
Avg Mkt Cap Rs m345,7178,168 4,232.4%   
No. of employees `000NANA-   
Total wages/salary Rs m4,927185 2,658.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m43,100135 31,978.2%  
Other income Rs m83578 1,076.5%   
Total revenues Rs m43,935212 20,692.8%   
Gross profit Rs m9,189-799 -1,149.5%  
Depreciation Rs m58143 1,337.6%   
Interest Rs m1839 1,942.6%   
Profit before tax Rs m9,260-775 -1,195.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,353-53 -4,419.7%   
Profit after tax Rs m6,907-722 -957.3%  
Gross profit margin %21.3-593.1 -3.6%  
Effective tax rate %25.46.9 369.8%   
Net profit margin %16.0-535.3 -3.0%  
BALANCE SHEET DATA
Current assets Rs m35,1851,966 1,789.9%   
Current liabilities Rs m10,3091,098 938.8%   
Net working cap to sales %57.7643.8 9.0%  
Current ratio x3.41.8 190.7%  
Inventory Days Days42 192.2%  
Debtors Days Days2477 0.4%  
Net fixed assets Rs m3,041257 1,181.6%   
Share capital Rs m213127 167.0%   
"Free" reserves Rs m25,366584 4,346.7%   
Net worth Rs m25,579711 3,598.3%   
Long term debt Rs m04 0.0%   
Total assets Rs m38,2262,223 1,719.5%  
Interest coverage x51.7-81.3 -63.5%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.10.1 1,859.8%   
Return on assets %18.5-32.0 -57.9%  
Return on equity %27.0-101.5 -26.6%  
Return on capital %36.9-107.1 -34.5%  
Exports to sales %0.769.1 1.0%   
Imports to sales %12.3547.1 2.3%   
Exports (fob) Rs m29593 317.2%   
Imports (cif) Rs m5,306737 719.5%   
Fx inflow Rs m35393 379.6%   
Fx outflow Rs m5,389737 730.8%   
Net fx Rs m-5,035-644 781.5%   
CASH FLOW
From Operations Rs m7,267-960 -756.8%  
From Investments Rs m-718558 -128.6%  
From Financial Activity Rs m-5,818349 -1,669.1%  
Net Cashflow Rs m731-53 -1,372.6%  

Share Holding

Indian Promoters % 0.0 65.0 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.7 0.9 850.5%  
FIIs % 0.2 0.5 48.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 35.0 71.4%  
Shareholders   90,567 81,039 111.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   CIPLA    SUN PHARMA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    



Today's Market

Sensex, Nifty End Marginally Lower; Metal Stocks Witness Selling(Closing)

After opening on a positive note, Indian share markets failed to keep up early gains and ended the day marginally lower.

Related Views on News

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

Nifty Pharma Index - Bulls are Losing the Ground (Views On News)

Mar 16, 2022

For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far...(Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022(Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022(Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look...(Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better?(Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


May 23, 2022 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA 8-QTR ANALYSIS

COMPARE ABBOTT INDIA WITH

MARKET STATS